Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Eur J Cancer. 2008 Aug 20;44(16):2518–2525. doi: 10.1016/j.ejca.2008.07.021

Fig. 2.

Fig. 2

(A) ILK is not expressed in normal hyaline cartilage. (B) Weak positivity for ILK in an ECH. (C) LG CHS displaying moderate ILK immunoexpression. (D) Malignant cells of a HG CHS exhibiting strong, cytoplasmic ILK immunostaining (A–D, original magnification ×20). Scale bar = 50 μm.